pillbase.ru

Milnacipran Pierre Fabre Medicament

Active substance: milnacipran

milnacipran

Centralised EU authorisationActive

Marketing holder: Pierre Fabre Medicament

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Иксел
    капсулы, 25 мг (original in Russian, GRLS)
    П N011787/01
    Пьер Фабр Медикамент Продакшн
US 27All products in this country (27)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c4-cf5b-71ac-9628-3887e1e1b420;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a70d-70a0-b411-2d1ddcf07549,01a1208d-0807-7161-8c22-ff1d1b6b10da,01a1208d-8f08-70e4-a9a0-2672ec137ad8,01a1208e-1a00-756e-9958-a70ecc7bf1c1,01a1208e-1a0a-7cc9-b002-49a0c9d53f5e;count=27 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/001034
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/001034 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/001034 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/001034 · Verified 2026-10-09